World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Germany
2026

D-Index & Metrics

Biology and Biochemistry

D-Index
99
Citations
32855
World Ranking
1599
National Ranking
104

Research.com Recognitions

  • 2026 - Research.com Biology and Biochemistry in Germany Leader Award

Overview

Bernd Dörken is affiliated with Charité - University Medicine Berlin in Germany. Their research spans fields within Medicine and Biochemistry, Genetics and Molecular Biology, focusing primarily on Hematology, Molecular Biology, and Oncology as key subfields. The main topics covered in their work include Acute Myeloid Leukemia Research, Multiple Myeloma Research and Treatments, Histone Deacetylase Inhibitors Research, Cancer-related Molecular Pathways, Pancreatic and Hepatic Oncology Research, and RNA modifications and cancer.

Their recent publications reflect an engagement with clinical and molecular aspects of cancer therapies. Notable papers include:

  • Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study, 2023, Annals of Hematology
  • Withdrawal: p14ARF induces G2 cell cycle arrest in p53- and p21-deficient cells by down-regulating p34cdc2 kinase activity, 2023, Journal of Biological Chemistry

Dörken frequently collaborates with other researchers in their field. Their regular co-authors include:

  • Dietger Niederwieser
  • Thomas Lang
  • Rainer Krahl
  • Thomas Heinicke
  • Georg Maschmeyer

Their research contributions are published in venues such as Annals of Hematology and Journal of Biological Chemistry, indicating a focus on both clinical hematology and molecular biology contexts.

Best Publications

  • Oncogene-induced senescence as an initial barrier in lymphoma development

    Melanie Braig;Soyoung Lee;Christoph Loddenkemper;Cornelia Rudolph

  • Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

    Andreas Engert;Annette Plütschow;Hans Theodor Eich;Andreas Lohri

  • Senescence-associated reprogramming promotes cancer stemness

    Maja Milanovic;Dorothy N. Y. Fan;Dimitri Belenki;J. Henry M. Däbritz

  • A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes.

    Anja Löffler;Peter Kufer;Peter Kufer;Peter Kufer;Ralf Lutterbüse;Ralf Lutterbüse;Ralf Lutterbüse;Florian Zettl;Florian Zettl;Florian Zettl

  • Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression.

    Ralf C. Bargou;Karsten Jürchott;Christian Wagener;Stephan Bergmann

  • Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial

    Hans Theodor Eich;Volker Diehl;Helen Görgen;Thomas Pabst

  • Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-κB

    Stephan Mathas;Stephan Mathas;Michael Hinz;Ioannis Anagnostopoulos;Daniel Krappmann

  • Antisense therapy in oncology: new hope for an old idea?

    Ingo Tamm;Bernd Dörken;Gunther Hartmann

  • Nuclear Factor κB–dependent Gene Expression Profiling of Hodgkin's Disease Tumor Cells, Pathogenetic Significance, and Link to Constitutive Signal Transducer and Activator of Transcription 5a Activity

    Michael Hinz;Petra Lemke;Ioannis Anagnostopoulos;Christine Hacker

  • Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma

    Björn Lamprecht;Korden Walter;Stephan Kreher;Stephan Kreher;Raman Kumar

  • Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.

    Daniel Krappmann;Florian Emmerich;Florian Emmerich;Uwe Kordes;Erika Scharschmidt

  • Overexpression of I Kappa B Alpha Without Inhibition of NF-κB Activity and Mutations in the I Kappa B Alpha Gene in Reed-Sternberg Cells

    Florian Emmerich;Martina Meiser;Martina Meiser;Michael Hummel;Michael Hummel;Gudrun Demel;Gudrun Demel

  • Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.

    Michael Hinz;Peter Löser;Peter Löser;Stephan Mathas;Stephan Mathas;Daniel Krappmann;Daniel Krappmann

  • Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.

    Thomas Wieder;Frank Essmann;Frank Essmann;Frank Essmann;Aram Prokop;Aram Prokop;Aram Prokop;Karin Schmelz;Karin Schmelz;Karin Schmelz

  • Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell lines

    Stephan Hailfinger;Hendrik Nogai;Christiane Pelzer;Maike Jaworski

  • Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.

    R C Bargou;C Wagener;K Bommert;M Y Mapara

  • Time-intensified dexamethasone/cisplatin/cytarabine:an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease

    A. Josting;C. Rudolph;M. Reiser;M. Mapara

  • Macrophage inflammatory protein 1-alpha (MIP-1α) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells

    Suzanne Lentzsch;Margarete Gries;Margarete Gries;Martin Janz;Martin Janz;Ralf Bargou;Ralf Bargou

  • Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleoprotein A1 by caspase 3.

    Ekkehard Brockstedt;Anke Rickers;Susanne Kostka;Andreas Laubersheimer

  • Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells

    Clarissa von Haefen;Thomas Wieder;Bernd Gillissen;Lilian Stärck

Frequent Co-Authors

Peter T. Daniel
Peter T. Daniel Max Delbrück Center for Molecular Medicine
Thomas Wieder
Thomas Wieder University of Tübingen
Klaus Schulze-Osthoff
Klaus Schulze-Osthoff University of Tübingen
Frank Essmann
Frank Essmann University of Tübingen
Thomas Blankenstein
Thomas Blankenstein Max Delbrück Center for Molecular Medicine
Daniel Krappmann
Daniel Krappmann Ludwig-Maximilians-Universität München
Claus Scheidereit
Claus Scheidereit Max Delbrück Center for Molecular Medicine
Volker Diehl
Volker Diehl University of Cologne
Andreas Engert
Andreas Engert University of Cologne
Alexandra Aicher
Alexandra Aicher Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Biology or Biochemistry opens doors to several related fields that offer both flexibility and rewarding career opportunities. Many top universities and schools in the USA now offer accessible online programs suited for a variety of interests and professional goals.

For students interested in healthcare and pharmaceuticals, enrolling in an online pharmacy school can lead to careers as pharmacists or in pharmaceutical research. If your passion lies in health, fitness, and human movement, consider an exercise science online degree or a kinesiology online degree. Both fields provide a strong foundation for jobs in sports medicine, rehabilitation, and wellness coaching.

For those looking to fast-track into advanced nursing roles, the fastest pmhnp program offers a path to become a Psychiatric-Mental Health Nurse Practitioner. Each of these options can complement a background in Biology or Biochemistry and expand your professional possibilities in the dynamic health sciences landscape.

Best Scientists Citing Bernd Dörken

Trending Scientists

Recently Published Articles